Antimitotic actions of dopaminergic drugs on human pituitary tumors
- 1 January 1984
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 86 references indexed in Scilit:
- Dopamine Creates a Physical Barrier to Inhibit Prolactin Release in Mammotrophs of Estradiol-Primed Male RatsNeuroendocrinology, 1983
- The link between secretion and mitosis in the endocrine glandsLife Sciences, 1982
- DNA polymerases in the rat pituitary glandMolecular and Cellular Endocrinology, 1980
- DNA synthesis in the pituitary gland of the rat: Effect of sulpiride and clomipheneCellular and Molecular Life Sciences, 1979
- Cell proliferation in the rat pituitary gland: A mechanism of control in prolactin cellsCellular and Molecular Life Sciences, 1979
- Reduction in Size of a Pituitary Tumor by Bromocriptine TherapyNew England Journal of Medicine, 1979
- Effect of hyperprolactinemia and 2-BR-α-ergocryptine on neuroendocrine mechanism(s) for gonadotropin controlLife Sciences, 1978
- Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cellsNature, 1975
- Inhibition by 2-Br-α-ergocryptine-mesilate (CB 154) of suckling-induced pituitary prolactin depletion in lactating ratsCellular and Molecular Life Sciences, 1974
- Effects of ergocornine and 2-Br-α-ergokryptin (CB-154) on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in miceCellular and Molecular Life Sciences, 1970